rrrrrrry
Lv6
1710 积分
2024-03-04 加入
-
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
1小时前
待确认
-
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
1小时前
待确认
-
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
1小时前
待确认
-
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
1小时前
待确认
-
Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC
13天前
已完结
-
Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC
13天前
已完结
-
A pooled analysis of datopotamab deruxtecan in patients with EGFR–mutated NSCLC
14天前
已完结
-
Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial
20天前
已完结
-
Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A phase II multi-center trial
21天前
已完结
-
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
21天前
已完结